{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:19:07Z","timestamp":1783664347261,"version":"3.55.0"},"reference-count":74,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"\n OBJECTIVE<\/jats:title>\n Brain metastases (BMs) secondary to sarcoma are rare, and their incidence ranges from 1% to 8% of all bone and soft tissue sarcomas. Although stereotactic radiosurgery (SRS) is widely used for BMs, only a few papers have reported on SRS for sarcoma metastasizing to the brain. The purpose of this study was to evaluate the safety and effectiveness of SRS for sarcoma BM.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n The authors retrospectively reviewed the clinical and radiological outcomes of patients with BM secondary to histopathologically confirmed sarcoma treated with SRS, either as primary treatment or as adjuvant therapy after surgery, at their institution between January 2005 and September 2022. They also compared the outcomes of patients with hemorrhagic lesions and of those without.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n \n Twenty-three patients (9 females) with 150 BMs secondary to sarcoma were treated with CyberKnife SRS. Median age at the time of treatment was 48.22 years (range 4\u201376 years). The most common primary tumor sites were the heart, lungs, uterus, upper extremities, chest wall, and head and neck. The median Karnofsky Performance Status on presentation was 73.28 (range 40\u2013100). Eight patients underwent SRS as a primary treatment and 15 as adjuvant therapy to the resection cavity. The median tumor volume was 24.1 cm\n 3<\/jats:sup>\n (range 0.1\u2013150.3 cm\n 3<\/jats:sup>\n ), the median marginal dose was 24 Gy (range 18\u201330 Gy) delivered in a median of 1 fraction (range 1\u20135) to a median isodose line of 76%. The median follow-up was 8 months (range 2\u201340 months). Median progression-free survival and overall survival were 5.3 months (range 0.4\u201332 months) and 8.2 months (range 0.1\u201340), respectively. The 3-, 6-, and 12-month local tumor control (LTC) rates for all lesions were respectively 78%, 52%, and 30%. There were no radiation-induced adverse effects. LTC at the 3-, 6-, and 12-month follow-ups was better in patients without hemorrhagic lesions (100%, 70%, and 40%, respectively) than in those with hemorrhagic lesions (68%, 38%, and 23%, respectively).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n SRS, both as a primary treatment and as adjuvant therapy to the resection cavity after surgery, is a safe and relatively effective treatment modality for sarcoma BMs. Nonhemorrhagic lesions show better LTC than hemorrhagic lesions. Larger studies aiming to validate these results are encouraged.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2023.5.focus23168","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T07:14:39Z","timestamp":1690874079000},"page":"E7","source":"Crossref","is-referenced-by-count":7,"title":["Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience"],"prefix":"10.3171","volume":"55","author":[{"given":"Aroosa","family":"Zamarud","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Park","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Y. A.","family":"Dadey","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly H.","family":"Yoo","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelan J.","family":"Marianayagam","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulas","family":"Yener","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Arthur","family":"Szalkowski","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erqi","family":"Pollom","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Soltys","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Chang","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Meola","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"10","key":"b1","series-title":"J Am Acad Orthop Surg Glob Res Rev","first-page":"e21.00219","article-title":"Brain metastases in patients with soft-tissue sarcomas: management and survival\u2014a SEER population-based cohort study","volume":"5","author":"Gonzalez MR","year":"2021","unstructured":"Gonzalez MR, Bryce-Alberti M, Leon-Abarca JA, Pretell-Mazzini J. Brain metastases in patients with soft-tissue sarcomas: management and survival\u2014a SEER population-based cohort study. J Am Acad Orthop Surg Glob Res Rev. 2021;5(10):e21.00219.34618750"},{"issue":"8","key":"b2","series-title":"Oncologist","first-page":"948","article-title":"Brain metastases from adult sarcoma: prognostic factors and impact of treatment. A retrospective analysis from the French Sarcoma Group (GSF\/GETO)","volume":"23","author":"Chaigneau L","year":"2018","unstructured":"Chaigneau L, Patrikidou A, Ray-Coquard I, Brain metastases from adult sarcoma: prognostic factors and impact of treatment. A retrospective analysis from the French Sarcoma Group (GSF\/GETO). Oncologist. 2018;23(8):948\u2013955.29934413"},{"issue":"3","key":"b3","series-title":"J Neurooncol","first-page":"373","article-title":"Sarcoma metastatic to the brain: a series of 35 cases and considerations from 27 years of experience","volume":"98","author":"Salvati M","year":"2010","unstructured":"Salvati M, D\u2019Elia A, Frati A, Santoro A. Sarcoma metastatic to the brain: a series of 35 cases and considerations from 27 years of experience. J Neurooncol. 2010;98(3):373\u2013377."},{"issue":"1","key":"b4","series-title":"J Neurosurg","first-page":"181","article-title":"Surgical management of metastatic sarcoma to the brain","volume":"110","author":"Fox BD","year":"2009","unstructured":"Fox BD, Patel A, Suki D, Rao G. Surgical management of metastatic sarcoma to the brain. J Neurosurg. 2009;110(1):181\u2013186."},{"issue":"15 suppl","key":"b5","series-title":"J Clin Oncol","first-page":"10591","article-title":"Brain metastases in sarcoma patients: incidence and outcome","volume":"32","author":"Hoiczyk M","year":"2014","unstructured":"Hoiczyk M, Herbrik M, Grabellus F, Brain metastases in sarcoma patients: incidence and outcome. J Clin Oncol. 2014;32(15 suppl):10591."},{"issue":"1","key":"b6","series-title":"J Neurooncol","first-page":"43","article-title":"Brain metastasis in pediatric extracranial solid tumors: survey and literature review","volume":"71","author":"Kebudi R","year":"2005","unstructured":"Kebudi R, Ayan I, G\u00f6rg\u00fcn O, A\u011fao\u011flu FY, Vural S, Darendeliler E. Brain metastasis in pediatric extracranial solid tumors: survey and literature review. J Neurooncol. 2005;71(1):43\u201348.15719274"},{"issue":"10","key":"b7","series-title":"Cancer","first-page":"2706","article-title":"Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients","volume":"94","author":"Espat NJ","year":"2002","unstructured":"Espat NJ, Bilsky M, Lewis JJ, Leung D, Brennan MF. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients. Cancer. 2002;94(10):2706\u20132711."},{"issue":"5)(suppl 5","key":"b8","series-title":"Ann Surg Oncol","first-page":"962","article-title":"Sarcoma brain metastases: 28 years of experience at a single institution","volume":"23","author":"Al Sannaa G","year":"2016","unstructured":"Al Sannaa G, Watson KL, Olar A, Sarcoma brain metastases: 28 years of experience at a single institution. Ann Surg Oncol. 2016;23(5)(suppl 5):962\u2013967."},{"issue":"4","key":"b9","series-title":"Clin Exp Metastasis","first-page":"345","article-title":"Postoperative brain metastases in soft tissue sarcomas","volume":"32","author":"Urakawa H","year":"2015","unstructured":"Urakawa H, Tsukushi S, Kozawa E, Postoperative brain metastases in soft tissue sarcomas. Clin Exp Metastasis. 2015;32(4):345\u2013351.25795392"},{"key":"b10","series-title":"Rare Tumors","first-page":"20363613211026151","article-title":"Outcomes of brain metastasis in high-grade bone and soft tissue sarcoma: An analysis of clinicopathological characteristics and survival data","volume":"13","author":"Gusho CA","year":"2021","unstructured":"Gusho CA, Blank AT, Batus M. Outcomes of brain metastasis in high-grade bone and soft tissue sarcoma: An analysis of clinicopathological characteristics and survival data. Rare Tumors. 2021;13:20363613211026151.34221290"},{"issue":"11","key":"b11","series-title":"Int J Clin Oncol","first-page":"1995","article-title":"Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan","volume":"25","author":"Deguchi S","year":"2020","unstructured":"Deguchi S, Nakasu Y, Sakaida T, Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan. Int J Clin Oncol. 2020;25(11):1995\u20132005.32648133"},{"issue":"11","key":"b12","series-title":"Int J Clin Oncol","first-page":"1767","article-title":"Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review","volume":"27","author":"Wang Y","year":"2022","unstructured":"Wang Y, Delisle M, Smith D, Alshamsan B, Srikanthan A. Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review. Int J Clin Oncol. 2022;27(11):1767\u20131779.35994183"},{"issue":"14","key":"b13","series-title":"Clin Cancer Res","first-page":"4834","article-title":"Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER","volume":"17","author":"Brufsky AM","year":"2011","unstructured":"Brufsky AM, Mayer M, Rugo HS, Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res. 2011;17(14):4834\u20134843.21768129"},{"key":"b14","series-title":"OncoTargets Ther","first-page":"9663","article-title":"Temozolomide combined with capecitabine in the treatment of mixed neuroendocrine carcinoma of the lung with poor tolerance after repeated radiochemotherapy: a case report and literature review","volume":"12","author":"Zhang B","year":"2019","unstructured":"Zhang B, Wang D, Zhang X, Temozolomide combined with capecitabine in the treatment of mixed neuroendocrine carcinoma of the lung with poor tolerance after repeated radiochemotherapy: a case report and literature review. OncoTargets Ther. 2019;12:9663\u20139668."},{"issue":"5","key":"b15","series-title":"Nat Rev Cancer","first-page":"352","article-title":"Brain metastases as preventive and therapeutic targets","volume":"11","author":"Steeg PS","year":"2011","unstructured":"Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. 2011;11(5):352\u2013363.21472002"},{"key":"b16","series-title":"Front Oncol","first-page":"161","article-title":"Mechanisms and therapy for cancer metastasis to the brain","volume":"8","author":"Franchino F","year":"2018","unstructured":"Franchino F, Rud\u00e0 R, Soffietti R. Mechanisms and therapy for cancer metastasis to the brain. Front Oncol. 2018;8:161."},{"issue":"2","key":"b17","series-title":"Front Biosci (Elite Ed)","first-page":"233","article-title":"Biology and treatment of metastasis of sarcoma to the brain","volume":"8","author":"Ahmad O","year":"2016","unstructured":"Ahmad O, Chan M, Savage P, Watabe K, Lo HW, Qasem S. Biology and treatment of metastasis of sarcoma to the brain. Front Biosci (Elite Ed). 2016;8(2):233\u2013244."},{"issue":"7","key":"b18","series-title":"J Surg Oncol","first-page":"765","article-title":"Brain, the last fortress of sarcoma: similar dismal outcome but discrepancy of timing of brain metastasis in bone and soft tissue sarcoma","volume":"104","author":"Chou YS","year":"2011","unstructured":"Chou YS, Liu CY, Chen WM, Brain, the last fortress of sarcoma: similar dismal outcome but discrepancy of timing of brain metastasis in bone and soft tissue sarcoma. J Surg Oncol. 2011;104(7):765\u2013770.21714120"},{"issue":"9","key":"b19","series-title":"Cardiovasc Intervent Radiol","first-page":"1255","article-title":"Basic knowledge in soft tissue sarcoma","volume":"42","author":"Bourcier K","year":"2019","unstructured":"Bourcier K, Le Cesne A, Tselikas L, Basic knowledge in soft tissue sarcoma. Cardiovasc Intervent Radiol. 2019;42(9):1255\u20131261.31236647"},{"issue":"2","key":"b20","series-title":"Neurosurg Clin N Am","first-page":"157","article-title":"The radiobiology of radiosurgery","volume":"10","author":"Kondziolka D","year":"1999","unstructured":"Kondziolka D, Lunsford LD, Flickinger JC. The radiobiology of radiosurgery. Neurosurg Clin N Am. 1999;10(2):157\u2013166.10099087"},{"issue":"2","key":"b21","series-title":"Clin Oncol (R Coll Radiol)","first-page":"71","article-title":"The role of biologically effective dose (BED) in clinical oncology","volume":"13","author":"Jones B","year":"2001","unstructured":"Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol).2001;13(2):71\u201381."},{"issue":"991","key":"b22","series-title":"Br J Radiol","first-page":"554","article-title":"21 years of biologically effective dose","volume":"83","author":"Fowler JF","year":"2010","unstructured":"Fowler JF. 21 years of biologically effective dose. Br J Radiol. 2010;83(991):554\u2013568.20603408"},{"key":"b23","series-title":"Front Oncol","first-page":"892139","article-title":"Evaluation of biological effective dose in Gamma Knife staged stereotactic radiosurgery for large brain metastases","volume":"12","author":"Cui T","year":"2022","unstructured":"Cui T, Weiner J, Danish S, Evaluation of biological effective dose in Gamma Knife staged stereotactic radiosurgery for large brain metastases. Front Oncol. 2022;12:892139.35847934"},{"issue":"2","key":"b24","series-title":"J Radiat Res (Tokyo)","first-page":"334","article-title":"Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis","volume":"55","author":"Inoue HK","year":"2014","unstructured":"Inoue HK, Sato H, Seto K, Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis. J Radiat Res (Tokyo). 2014;55(2):334\u2013342."},{"issue":"1","key":"b25","series-title":"Int J Radiat Oncol Biol Phys","first-page":"68","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano MT","year":"2021","unstructured":"Milano MT, Grimm J, Niemierko A, Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain. Int J Radiat Oncol Biol Phys. 2021;110(1):68\u201386.32921513"},{"key":"b26","series-title":"Surg Neurol Int","first-page":"32","article-title":"Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases","volume":"10","author":"Peng L","year":"2019","unstructured":"Peng L, Grimm J, Gui C, Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases. Surg Neurol Int. 2019;10:32.31528370"},{"issue":"11","key":"b27","series-title":"Anticancer Res","first-page":"5611","article-title":"Brain metastasis in soft tissue sarcoma at initial presentation","volume":"41","author":"Itoga R","year":"2021","unstructured":"Itoga R, Matsuoka M, Onodera T, Brain metastasis in soft tissue sarcoma at initial presentation. Anticancer Res. 2021;41(11):5611\u20135616.34732433"},{"key":"b28","series-title":"Rare Tumors","first-page":"2036361320960060","article-title":"Brain metastases from Truncal and extremity bone and soft tissue sarcoma: single institution study of oncologic outcomes","volume":"12","author":"Chan CM","year":"2020","unstructured":"Chan CM, Lindsay AD, Spiguel AR, Scarborough MT, Gibbs CP. Brain metastases from Truncal and extremity bone and soft tissue sarcoma: single institution study of oncologic outcomes. Rare Tumors. 2020;12:2036361320960060.33062230"},{"key":"b29","series-title":"J Clin Neurosci","first-page":"227","article-title":"Stereotactic radiosurgery in alveolar soft part sarcoma brain metastases: case series and literature review","volume":"93","author":"Lim JX","year":"2021","unstructured":"Lim JX, Karlsson B, Pang A, Vellayappan BA, Nga V. Stereotactic radiosurgery in alveolar soft part sarcoma brain metastases: case series and literature review. J Clin Neurosci. 2021;93:227\u2013230.34656252"},{"issue":"6","key":"b30","series-title":"Cancer","first-page":"1382","article-title":"Surgical treatment of brain metastases. Clinical and computerized tomography evaluation of the results of treatment","volume":"55","author":"Sundaresan N","year":"1985","unstructured":"Sundaresan N, Galicich JH. Surgical treatment of brain metastases. Clinical and computerized tomography evaluation of the results of treatment. Cancer. 1985;55(6):1382\u20131388.3971308"},{"issue":"2","key":"b31","series-title":"Int J Radiat Oncol Biol Phys","first-page":"513","article-title":"Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases","volume":"76","author":"Flannery T","year":"2010","unstructured":"Flannery T, Kano H, Niranjan A, Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases. Int J Radiat Oncol Biol Phys. 2010;76(2):513\u2013519.19467792"},{"issue":"5","key":"b32","series-title":"Am J Clin Oncol","first-page":"356","article-title":"Outcomes and the role of primary histology following LINAC-based stereotactic radiation for sarcoma brain metastases","volume":"43","author":"Sim AJ","year":"2020","unstructured":"Sim AJ, Ahmed KA, Keller A, Outcomes and the role of primary histology following LINAC-based stereotactic radiation for sarcoma brain metastases. Am J Clin Oncol. 2020;43(5):356\u2013361.32217854"},{"issue":"6","key":"b33","series-title":"J Neurosurg","first-page":"852","article-title":"Significance of hemorrhage into brain tumors: clinicopathological study","volume":"67","author":"Kondziolka D","year":"1987","unstructured":"Kondziolka D, Bernstein M, Resch L, Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg. 1987;67(6):852\u2013857.3316531"},{"issue":"3","key":"b34","series-title":"J Neurooncol","first-page":"257","article-title":"Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage","volume":"76","author":"Jung S","year":"2006","unstructured":"Jung S, Moon KS, Jung TY, Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage. J Neurooncol. 2006;76(3):257\u2013263.16158215"},{"issue":"3","key":"b35","series-title":"Eur J Radiol","first-page":"241","article-title":"Metastatic rhabdomyosarcoma presenting as intracranial hemorrhage: imaging findings","volume":"26","author":"Ahola DT","year":"1998","unstructured":"Ahola DT, Provenzale JM, Longee DC. Metastatic rhabdomyosarcoma presenting as intracranial hemorrhage: imaging findings. Eur J Radiol. 1998;26(3):241\u2013243.9587748"},{"key":"b36","series-title":"Front Oncol","first-page":"699860","article-title":"Preoperative metastatic brain tumor-associated intracerebral hemorrhage is associated with dismal prognosis","volume":"11","author":"Hamed M","year":"2021","unstructured":"Hamed M, Sch\u00e4fer N, Bode C, Preoperative metastatic brain tumor-associated intracerebral hemorrhage is associated with dismal prognosis. Front Oncol. 2021;11:699860.34595109"},{"issue":"1","key":"b37","series-title":"J Neuroimaging","first-page":"71","article-title":"Cerebral metastasis from heart angiosarcoma presenting as multiple hematomas","volume":"14","author":"Liassides C","year":"2004","unstructured":"Liassides C, Katsamaga M, Deretzi G, Koutsimanis V, Zacharakis G. Cerebral metastasis from heart angiosarcoma presenting as multiple hematomas. J Neuroimaging. 2004;14(1):71\u201373.14748213"},{"issue":"10","key":"b1","series-title":"J Am Acad Orthop Surg Glob Res Rev","first-page":"e21.00219","article-title":"Brain metastases in patients with soft-tissue sarcomas: management and survival\u2014a SEER population-based cohort study","volume":"5","author":"Gonzalez MR","year":"2021","unstructured":"Gonzalez MR, Bryce-Alberti M, Leon-Abarca JA, Pretell-Mazzini J. Brain metastases in patients with soft-tissue sarcomas: management and survival\u2014a SEER population-based cohort study. J Am Acad Orthop Surg Glob Res Rev. 2021;5(10):e21.00219.34618750"},{"issue":"8","key":"b2","series-title":"Oncologist","first-page":"948","article-title":"Brain metastases from adult sarcoma: prognostic factors and impact of treatment. A retrospective analysis from the French Sarcoma Group (GSF\/GETO)","volume":"23","author":"Chaigneau L","year":"2018","unstructured":"Chaigneau L, Patrikidou A, Ray-Coquard I, Brain metastases from adult sarcoma: prognostic factors and impact of treatment. A retrospective analysis from the French Sarcoma Group (GSF\/GETO). Oncologist. 2018;23(8):948\u2013955.29934413"},{"issue":"3","key":"b3","series-title":"J Neurooncol","first-page":"373","article-title":"Sarcoma metastatic to the brain: a series of 35 cases and considerations from 27 years of experience","volume":"98","author":"Salvati M","year":"2010","unstructured":"Salvati M, D\u2019Elia A, Frati A, Santoro A. Sarcoma metastatic to the brain: a series of 35 cases and considerations from 27 years of experience. J Neurooncol. 2010;98(3):373\u2013377."},{"issue":"1","key":"b4","series-title":"J Neurosurg","first-page":"181","article-title":"Surgical management of metastatic sarcoma to the brain","volume":"110","author":"Fox BD","year":"2009","unstructured":"Fox BD, Patel A, Suki D, Rao G. Surgical management of metastatic sarcoma to the brain. J Neurosurg. 2009;110(1):181\u2013186."},{"issue":"15 suppl","key":"b5","series-title":"J Clin Oncol","first-page":"10591","article-title":"Brain metastases in sarcoma patients: incidence and outcome","volume":"32","author":"Hoiczyk M","year":"2014","unstructured":"Hoiczyk M, Herbrik M, Grabellus F, Brain metastases in sarcoma patients: incidence and outcome. J Clin Oncol. 2014;32(15 suppl):10591."},{"issue":"1","key":"b6","series-title":"J Neurooncol","first-page":"43","article-title":"Brain metastasis in pediatric extracranial solid tumors: survey and literature review","volume":"71","author":"Kebudi R","year":"2005","unstructured":"Kebudi R, Ayan I, G\u00f6rg\u00fcn O, A\u011fao\u011flu FY, Vural S, Darendeliler E. Brain metastasis in pediatric extracranial solid tumors: survey and literature review. J Neurooncol. 2005;71(1):43\u201348.15719274"},{"issue":"10","key":"b7","series-title":"Cancer","first-page":"2706","article-title":"Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients","volume":"94","author":"Espat NJ","year":"2002","unstructured":"Espat NJ, Bilsky M, Lewis JJ, Leung D, Brennan MF. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients. Cancer. 2002;94(10):2706\u20132711."},{"issue":"5)(suppl 5","key":"b8","series-title":"Ann Surg Oncol","first-page":"962","article-title":"Sarcoma brain metastases: 28 years of experience at a single institution","volume":"23","author":"Al Sannaa G","year":"2016","unstructured":"Al Sannaa G, Watson KL, Olar A, Sarcoma brain metastases: 28 years of experience at a single institution. Ann Surg Oncol. 2016;23(5)(suppl 5):962\u2013967."},{"issue":"4","key":"b9","series-title":"Clin Exp Metastasis","first-page":"345","article-title":"Postoperative brain metastases in soft tissue sarcomas","volume":"32","author":"Urakawa H","year":"2015","unstructured":"Urakawa H, Tsukushi S, Kozawa E, Postoperative brain metastases in soft tissue sarcomas. Clin Exp Metastasis. 2015;32(4):345\u2013351.25795392"},{"key":"b10","series-title":"Rare Tumors","first-page":"20363613211026151","article-title":"Outcomes of brain metastasis in high-grade bone and soft tissue sarcoma: An analysis of clinicopathological characteristics and survival data","volume":"13","author":"Gusho CA","year":"2021","unstructured":"Gusho CA, Blank AT, Batus M. Outcomes of brain metastasis in high-grade bone and soft tissue sarcoma: An analysis of clinicopathological characteristics and survival data. Rare Tumors. 2021;13:20363613211026151.34221290"},{"issue":"11","key":"b11","series-title":"Int J Clin Oncol","first-page":"1995","article-title":"Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan","volume":"25","author":"Deguchi S","year":"2020","unstructured":"Deguchi S, Nakasu Y, Sakaida T, Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan. Int J Clin Oncol. 2020;25(11):1995\u20132005.32648133"},{"issue":"11","key":"b12","series-title":"Int J Clin Oncol","first-page":"1767","article-title":"Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review","volume":"27","author":"Wang Y","year":"2022","unstructured":"Wang Y, Delisle M, Smith D, Alshamsan B, Srikanthan A. Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review. Int J Clin Oncol. 2022;27(11):1767\u20131779.35994183"},{"issue":"14","key":"b13","series-title":"Clin Cancer Res","first-page":"4834","article-title":"Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER","volume":"17","author":"Brufsky AM","year":"2011","unstructured":"Brufsky AM, Mayer M, Rugo HS, Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res. 2011;17(14):4834\u20134843.21768129"},{"key":"b14","series-title":"OncoTargets Ther","first-page":"9663","article-title":"Temozolomide combined with capecitabine in the treatment of mixed neuroendocrine carcinoma of the lung with poor tolerance after repeated radiochemotherapy: a case report and literature review","volume":"12","author":"Zhang B","year":"2019","unstructured":"Zhang B, Wang D, Zhang X, Temozolomide combined with capecitabine in the treatment of mixed neuroendocrine carcinoma of the lung with poor tolerance after repeated radiochemotherapy: a case report and literature review. OncoTargets Ther. 2019;12:9663\u20139668."},{"issue":"5","key":"b15","series-title":"Nat Rev Cancer","first-page":"352","article-title":"Brain metastases as preventive and therapeutic targets","volume":"11","author":"Steeg PS","year":"2011","unstructured":"Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. 2011;11(5):352\u2013363.21472002"},{"key":"b16","series-title":"Front Oncol","first-page":"161","article-title":"Mechanisms and therapy for cancer metastasis to the brain","volume":"8","author":"Franchino F","year":"2018","unstructured":"Franchino F, Rud\u00e0 R, Soffietti R. Mechanisms and therapy for cancer metastasis to the brain. Front Oncol. 2018;8:161."},{"issue":"2","key":"b17","series-title":"Front Biosci (Elite Ed)","first-page":"233","article-title":"Biology and treatment of metastasis of sarcoma to the brain","volume":"8","author":"Ahmad O","year":"2016","unstructured":"Ahmad O, Chan M, Savage P, Watabe K, Lo HW, Qasem S. Biology and treatment of metastasis of sarcoma to the brain. Front Biosci (Elite Ed). 2016;8(2):233\u2013244."},{"issue":"7","key":"b18","series-title":"J Surg Oncol","first-page":"765","article-title":"Brain, the last fortress of sarcoma: similar dismal outcome but discrepancy of timing of brain metastasis in bone and soft tissue sarcoma","volume":"104","author":"Chou YS","year":"2011","unstructured":"Chou YS, Liu CY, Chen WM, Brain, the last fortress of sarcoma: similar dismal outcome but discrepancy of timing of brain metastasis in bone and soft tissue sarcoma. J Surg Oncol. 2011;104(7):765\u2013770.21714120"},{"issue":"9","key":"b19","series-title":"Cardiovasc Intervent Radiol","first-page":"1255","article-title":"Basic knowledge in soft tissue sarcoma","volume":"42","author":"Bourcier K","year":"2019","unstructured":"Bourcier K, Le Cesne A, Tselikas L, Basic knowledge in soft tissue sarcoma. Cardiovasc Intervent Radiol. 2019;42(9):1255\u20131261.31236647"},{"issue":"2","key":"b20","series-title":"Neurosurg Clin N Am","first-page":"157","article-title":"The radiobiology of radiosurgery","volume":"10","author":"Kondziolka D","year":"1999","unstructured":"Kondziolka D, Lunsford LD, Flickinger JC. The radiobiology of radiosurgery. Neurosurg Clin N Am. 1999;10(2):157\u2013166.10099087"},{"issue":"2","key":"b21","series-title":"Clin Oncol (R Coll Radiol)","first-page":"71","article-title":"The role of biologically effective dose (BED) in clinical oncology","volume":"13","author":"Jones B","year":"2001","unstructured":"Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol).2001;13(2):71\u201381."},{"issue":"991","key":"b22","series-title":"Br J Radiol","first-page":"554","article-title":"21 years of biologically effective dose","volume":"83","author":"Fowler JF","year":"2010","unstructured":"Fowler JF. 21 years of biologically effective dose. Br J Radiol. 2010;83(991):554\u2013568.20603408"},{"key":"b23","series-title":"Front Oncol","first-page":"892139","article-title":"Evaluation of biological effective dose in Gamma Knife staged stereotactic radiosurgery for large brain metastases","volume":"12","author":"Cui T","year":"2022","unstructured":"Cui T, Weiner J, Danish S, Evaluation of biological effective dose in Gamma Knife staged stereotactic radiosurgery for large brain metastases. Front Oncol. 2022;12:892139.35847934"},{"issue":"2","key":"b24","series-title":"J Radiat Res (Tokyo)","first-page":"334","article-title":"Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis","volume":"55","author":"Inoue HK","year":"2014","unstructured":"Inoue HK, Sato H, Seto K, Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis. J Radiat Res (Tokyo). 2014;55(2):334\u2013342."},{"issue":"1","key":"b25","series-title":"Int J Radiat Oncol Biol Phys","first-page":"68","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano MT","year":"2021","unstructured":"Milano MT, Grimm J, Niemierko A, Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain. Int J Radiat Oncol Biol Phys. 2021;110(1):68\u201386.32921513"},{"key":"b26","series-title":"Surg Neurol Int","first-page":"32","article-title":"Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases","volume":"10","author":"Peng L","year":"2019","unstructured":"Peng L, Grimm J, Gui C, Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases. Surg Neurol Int. 2019;10:32.31528370"},{"issue":"11","key":"b27","series-title":"Anticancer Res","first-page":"5611","article-title":"Brain metastasis in soft tissue sarcoma at initial presentation","volume":"41","author":"Itoga R","year":"2021","unstructured":"Itoga R, Matsuoka M, Onodera T, Brain metastasis in soft tissue sarcoma at initial presentation. Anticancer Res. 2021;41(11):5611\u20135616.34732433"},{"key":"b28","series-title":"Rare Tumors","first-page":"2036361320960060","article-title":"Brain metastases from Truncal and extremity bone and soft tissue sarcoma: single institution study of oncologic outcomes","volume":"12","author":"Chan CM","year":"2020","unstructured":"Chan CM, Lindsay AD, Spiguel AR, Scarborough MT, Gibbs CP. Brain metastases from Truncal and extremity bone and soft tissue sarcoma: single institution study of oncologic outcomes. Rare Tumors. 2020;12:2036361320960060.33062230"},{"key":"b29","series-title":"J Clin Neurosci","first-page":"227","article-title":"Stereotactic radiosurgery in alveolar soft part sarcoma brain metastases: case series and literature review","volume":"93","author":"Lim JX","year":"2021","unstructured":"Lim JX, Karlsson B, Pang A, Vellayappan BA, Nga V. Stereotactic radiosurgery in alveolar soft part sarcoma brain metastases: case series and literature review. J Clin Neurosci. 2021;93:227\u2013230.34656252"},{"issue":"6","key":"b30","series-title":"Cancer","first-page":"1382","article-title":"Surgical treatment of brain metastases. Clinical and computerized tomography evaluation of the results of treatment","volume":"55","author":"Sundaresan N","year":"1985","unstructured":"Sundaresan N, Galicich JH. Surgical treatment of brain metastases. Clinical and computerized tomography evaluation of the results of treatment. Cancer. 1985;55(6):1382\u20131388.3971308"},{"issue":"2","key":"b31","series-title":"Int J Radiat Oncol Biol Phys","first-page":"513","article-title":"Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases","volume":"76","author":"Flannery T","year":"2010","unstructured":"Flannery T, Kano H, Niranjan A, Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases. Int J Radiat Oncol Biol Phys. 2010;76(2):513\u2013519.19467792"},{"issue":"5","key":"b32","series-title":"Am J Clin Oncol","first-page":"356","article-title":"Outcomes and the role of primary histology following LINAC-based stereotactic radiation for sarcoma brain metastases","volume":"43","author":"Sim AJ","year":"2020","unstructured":"Sim AJ, Ahmed KA, Keller A, Outcomes and the role of primary histology following LINAC-based stereotactic radiation for sarcoma brain metastases. Am J Clin Oncol. 2020;43(5):356\u2013361.32217854"},{"issue":"6","key":"b33","series-title":"J Neurosurg","first-page":"852","article-title":"Significance of hemorrhage into brain tumors: clinicopathological study","volume":"67","author":"Kondziolka D","year":"1987","unstructured":"Kondziolka D, Bernstein M, Resch L, Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg. 1987;67(6):852\u2013857.3316531"},{"issue":"3","key":"b34","series-title":"J Neurooncol","first-page":"257","article-title":"Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage","volume":"76","author":"Jung S","year":"2006","unstructured":"Jung S, Moon KS, Jung TY, Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage. J Neurooncol. 2006;76(3):257\u2013263.16158215"},{"issue":"3","key":"b35","series-title":"Eur J Radiol","first-page":"241","article-title":"Metastatic rhabdomyosarcoma presenting as intracranial hemorrhage: imaging findings","volume":"26","author":"Ahola DT","year":"1998","unstructured":"Ahola DT, Provenzale JM, Longee DC. Metastatic rhabdomyosarcoma presenting as intracranial hemorrhage: imaging findings. Eur J Radiol. 1998;26(3):241\u2013243.9587748"},{"key":"b36","series-title":"Front Oncol","first-page":"699860","article-title":"Preoperative metastatic brain tumor-associated intracerebral hemorrhage is associated with dismal prognosis","volume":"11","author":"Hamed M","year":"2021","unstructured":"Hamed M, Sch\u00e4fer N, Bode C, Preoperative metastatic brain tumor-associated intracerebral hemorrhage is associated with dismal prognosis. Front Oncol. 2021;11:699860.34595109"},{"issue":"1","key":"b37","series-title":"J Neuroimaging","first-page":"71","article-title":"Cerebral metastasis from heart angiosarcoma presenting as multiple hematomas","volume":"14","author":"Liassides C","year":"2004","unstructured":"Liassides C, Katsamaga M, Deretzi G, Koutsimanis V, Zacharakis G. Cerebral metastasis from heart angiosarcoma presenting as multiple hematomas. J Neuroimaging. 2004;14(1):71\u201373.14748213"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/55\/2\/article-pE7.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/55\/2\/article-pE7.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/55\/2\/article-pE7.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:23:03Z","timestamp":1779524583000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/55\/2\/article-pE7.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":74,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2023.5.focus23168","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}